Holen Sie sich die Stockscreener-App
0.772
1.49%
-0.0117
Handel nachbörslich:
.80
0.028
+3.63%
Schlusskurs vom Vortag:
$0.7837
Offen:
$0.7799
24-Stunden-Volumen:
386.17K
Relative Volume:
0.45
Marktkapitalisierung:
$65.45M
Einnahmen:
$153.73M
Nettoeinkommen (Verlust:
$-106.79M
KGV:
-0.4337
EPS:
-1.78
Netto-Cashflow:
$-115.93M
1W Leistung:
-5.59%
1M Leistung:
+1.38%
6M Leistung:
-55.63%
1J Leistung:
-76.02%
1-Tages-Spanne:
$0.7707
$0.8009
1-Wochen-Bereich:
$0.76
$0.8402
52-Wochen-Spanne:
$0.5231
$5.17
Sutro Biopharma Inc Stock (STRO) Company Profile
Firmenname
Sutro Biopharma Inc
Sektor
Branche
Telefon
650-392-8412
Adresse
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie STRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.772 | 66.44M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-03-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-05-08 | Eingeleitet | BofA Securities | Buy |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-03-21 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-12-03 | Eingeleitet | Stifel | Buy |
| 2020-09-02 | Eingeleitet | Jefferies | Buy |
| 2020-07-16 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-13 | Eingeleitet | SunTrust | Buy |
| 2019-10-07 | Eingeleitet | BTIG Research | Buy |
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
| 2019-04-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-10-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-10-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-10-22 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten
Sutro Biopharma Inc. stock momentum explainedJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser
Strategies to average down on Sutro Biopharma Inc.2025 Dividend Review & Community Driven Trade Alerts - Newser
Pattern recognition hints at Sutro Biopharma Inc. upsideTrend Reversal & Low Volatility Stock Recommendations - Newser
What is the target price for Sutro Biopharma Inc. stockFree Growth Stock Screener - thegnnews.com
Sutro Biopharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Detecting support and resistance levels for Sutro Biopharma Inc.Low Risk High Confidence Watchlist Builder - Newser
Real time breakdown of Sutro Biopharma Inc. stock performanceFree Day Trading Signals With High Precision - Newser
Chart based analysis of Sutro Biopharma Inc. trendsPortfolio Booster Strategy with Trend Confidence - Newser
Has Sutro Biopharma Inc. formed a bullish divergenceMomentum Detection with Entry Optimization - Newser
Sutro Biopharma Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates - MSN
Sutro Biopharma's Strategic Turnaround: A Path to Profitability Amidst Industry Challenges - AInvest
Sutro Biopharma’s Strategic Shift and Pipeline Developments: A Hold Rating Amid Transitional Phase - TipRanks
Sutro Biopharma Advances ADC Pipeline and Reports Q2 2025 Results - TipRanks
Sutro Biopharma 2025 Q2 Earnings Significant Net Loss Reduction - AInvest
SUTRO BIOPHARMA, INC. SEC 10-Q Report - TradingView
Sutro Biopharma earnings beat by $0.27, revenue topped estimates - Investing.com Canada
SUTRO BIOPHARMA Earnings Results: $STRO Reports Quarterly Earnings - Quiver Quantitative
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Advances Pipeline with Strategic Initiatives - Quiver Quantitative
Sutro Reports 148% Revenue Growth as ADC Pipeline Expands, FDA Partnership Accelerates Development - Stock Titan
Chart overlay techniques for tracking Sutro Biopharma Inc.Low Drawdown Picks with Weekly Updates - Newser
Has Sutro Biopharma Inc. found a price floorTechnical Safety Zone Pattern Recognition - Newser
Real time scanner hits for Sutro Biopharma Inc. explainedBreakout Watcher with Entry and Exit Alerts - Newser
Sutro Biopharma Inc. Inches Above Key Support — Safe to HoldConfirmed Setup With Expert Accuracy Supported - beatles.ru
Using Ichimoku Cloud for Sutro Biopharma Inc. technicalsFast Return Equity Forecast With Logic - Newser
News impact scoring models applied to Sutro Biopharma Inc.Free Daily Momentum Screener With Alerts - Newser
Combining price and volume data for Sutro Biopharma Inc.Price Spike Prediction for Active Traders - Newser
Sutro Biopharma Inc. stock trend outlook and recovery pathFree Reliable Investment Entry Point Signals - Newser
Is Sutro Biopharma Inc. stock overvalued or undervaluedTake advantage of unprecedented market momentum - Jammu Links News
What makes Sutro Biopharma Inc. stock price move sharplyFree Community Strategy With High Win Rate - Newser
What institutional investors are buying Sutro Biopharma Inc. stockMaximize gains with proven stock analysis - Jammu Links News
What is the risk reward ratio of investing in Sutro Biopharma Inc. stockFree Stock Market Query - Jammu Links News
Does Sutro Biopharma Inc. stock perform well during market downturnsBuild a diversified portfolio for sustainable growth - Jammu Links News
How does Sutro Biopharma Inc. generate profit in a changing economyExceptional return forecasts - Jammu Links News
How Sutro Biopharma Inc. stock performs during market volatilityReversal Signal Prediction Based on Volume - newser.com
How strong is Sutro Biopharma Inc. company’s balance sheetSuperior capital gains - Jammu Links News
What are the technical indicators suggesting about Sutro Biopharma Inc.Achieve exceptional returns with expert guidance - Jammu Links News
Is Sutro Biopharma Inc. a growth stock or a value stockMaximize returns with disciplined trading approaches - Jammu Links News
How many analysts rate Sutro Biopharma Inc. as a “Buy”Outstanding investment returns - Jammu Links News
Why Sutro Biopharma Inc. stock attracts strong analyst attentionShort Term Gain Strategy with AI Logic - Newser
Institutional scanner results for Sutro Biopharma Inc.Free Stock Portfolio Allocation Guidance - Newser
Understanding Sutro Biopharma Inc.’s price movementFree Stock Portfolio Allocation Guidance - Newser
Is Sutro Biopharma Inc. forming a bottoming baseDaily Technical Forecast for Quick Gains - Newser
Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):